We use cookies on our website, which are text files containing small amounts of information that are downloaded to your computer or mobile device. To find out more about the cookies we use please click here.

Some of these cookies are strictly necessary for operation of this site. Other, non-essential cookies are used for measuring website performance (which is all aggregated and anonymised) and may share this information with Google. To consent to non-essential cookies, click "Accept all non-essential cookies".

Concepta secures partnership with Walgreens Boots Alliance

12 March 2019

Mercia Technologies PLC (AIM: MERC), the national investment group focused on the identification, creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, is pleased to note that AIM listed portfolio company Concepta Plc ("Concepta") has today announced a commercial partnership with Walgreens Boots Alliance for the supply of its revolutionary women's fertility and hormone testing product, myLotus®; an important milestone for the company as it forms part of the myLotus® roll-out plan across Europe.

Mercia holds a 18.2% direct equity stake in Concepta, having worked with the company via its managed funds before making its first balance sheet investment in May 2016.

Peter Dines, Chief Operating Officer at Mercia and a non-executive director of Concepta, said: "Securing a partnership with such a leading retailer as Walgreens Boots Alliance is validation that Concepta has developed a product with significant commercial appeal. This new partnership will play a pivotal role in myLotus® being more widely available across the UK and overseas."

© Mercia Technologies 2019

Terms and conditions Privacy policy

Designed and built by Onespacemedia